English
Italiano
Deutsch
日本語
中文
Español
Chengdu Tianfu Biotechnology Industry Incubation Park
Chengdu, China
Are you interested in GLP-1 treatment? Do you have any doubts about it?
Stevanato Group and Datwyler Healthcare teamed up with BioValley to hold a GLP-1 city tour event, aiming to share insights around technological innovation, dedicated product solutions and collaboration opportunities for GLP-1.
Join us!
Benefiting from the expansion of the hypoglycemic and weight management markets, GLP-1 drugs have continuously broken new sales records in China in recent years. Many domestic pharmaceutical companies have also made GLP-1 biosimilars a development focus, which has driven the development of the entire industry chain from drug development to downstream formulation production, high-value consumables, pharmaceutical packaging materials. As a result, GLP-1 drugs and their entire industry chain have become a hot topic in the field of biopharmaceuticals.
We also well-known experts and business representatives in the industry to jointly discuss the current situation, challenges, and future development trends of the GLP-1 market.
Daniel Martinez - Product Management DCS & Analytical Services
As a one-stop solution provider, how can we support pharma companies across their entire GLP-1 portfolio? Daniel will illustrate you challenges and viable solutions from the very beginning of the drug lifecycle.
13:00-13:30
Guest sign in (signature photo)
13:30-13:50
Welcome speech
13:50-14:30
Progress in clinical development of GLP-1 drugs worldwide
By Zhang Lin, Head of Medical Department, BENEMAE
14:30-15:10
Best choice of pharma packaging for biologics：GLP-1 as example
By Wu Guangming，Technology & Scientific expert, Datwyler
15:10-15:50
Discovery and clinical translation of innovative multi-target agonists targeting GLP-1R/GIPR/GCGR
By Fang Yongliang, COO, DOER BIOLOGICS
15:50-16:10
Tea Break
16:10-16:50
GLP-1: Ensuring better performance, flexibility, and faster time to market with integrated solutions
By Daniel Martinez, Stevanato Group Product Manager for Syringes, Components, and Analytical Services
16:50-17:30
GLP-1 wins 'Nobel Prize Wind vane', GLP-1, GIP, GCG triple target drugs rise
By Song Wenxin, Vice GM, CSO, Mingwei Biotechnology
17:30
Group Photo